About Neuronetics, Inc. 
Neuronetics, Inc.
Pharmaceuticals & Biotechnology
Neuronetics, Inc. is commercial-stage medical technology company. The Company is focused on the design and development of medical devices to treat psychiatric disorders. The Company’s principal product is NeuroStar Advanced Therapy System. It is a non-invasive treatment that uses transcranial magnetic stimulation (TMS) to create a pulsed magnetic field to induce electrical pulses for stimulating certain areas of the brain associated with mood. The system is used to treat adult patients with major depressive disorders. The Company offers its therapy systems to psychiatrist offices in the United States.
Company Coordinates 
Company Details
3222 Phoenixville Pike , MALVERN PA : 19355-9615
Registrar Details
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 21 Schemes (10.28%)
Foreign Institutions
Held by 34 Foreign Institutions (4.49%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
Mr. Brian Farley
Independent Non-Executive Chairman of the Board
Mr. Keith Sullivan
President, Chief Executive Officer, Director
Mr. John Bakewell
Director
Ms. Sheryl Conley
Independent Director
Dr. Wilfred Jaeger
Independent Director
Mr. Glenn Muir
Independent Director
Revenue and Profits:
Net Sales:
37 Million
(Quarterly Results - Sep 2025)
Net Profit:
-9 Million
Pharmaceuticals & Biotechnology
USD 132 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
1.34
-161.16%
4.81






